| Land | Impfungen | Impfrate | Impfstoffe |
| Afghanistan | 18.370.386 | 47,190% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Albania | 1.279.333 | 44,455% | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V |
| Algeria | 6.481.186 | 14,780% | Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V |
| Andorra | 53.501 | 69,244% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Angola | 9.609.080 | 29,237% | Oxford/AstraZeneca |
| Anguilla | 10.380 | 69,191% | Oxford/AstraZeneca, Pfizer/BioNTech |
| Antigua and Barbuda | 62.384 | 63,704% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Argentina | 34.900.613 | 77,221% | CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Armenia | 1.030.758 | 34,785% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, Sputnik Light, Sputnik V |
| Aruba | 84.368 | 79,021% | Pfizer/BioNTech |
| Australia | 21.647.523 | 84,893% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Austria | 6.683.263 | 74,206% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK, Valneva |
| Azerbaijan | 4.862.494 | 47,957% | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V |
| Bahamas | 166.972 | 42,460% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech |
| Bahrain | 1.226.796 | 72,097% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Bangladesh | 142.201.684 | 86,345% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac |
| Barbados | 155.047 | 53,954% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Belarus | 6.414.996 | 67,888% | KoviVac/Chumakov, Sinopharm/Beijing, Sputnik Light, Sputnik V |
| Belgium | 9.170.945 | 79,131% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Belize | 221.402 | 55,682% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Benin | 2.742.837 | 22,625% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Bermuda | 47.657 | 76,529% | Oxford/AstraZeneca, Pfizer/BioNTech |
| Bhutan | 677.669 | 87,825% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Bolivia | 6.160.585 | 52,776% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Bonaire Sint Eustatius and Saba | 16.736 | 63,827% | Moderna, Pfizer/BioNTech |
| Bosnia and Herzegovina | 846.080 | 25,789% | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V |
| Botswana | 1.663.490 | 70,738% | Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Brazil | 176.164.186 | 82,878% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| British Virgin Islands | 18.261 | 60,393% | Johnson&Johnson, Oxford/AstraZeneca |
| Brunei | 446.714 | 102,110% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Bulgaria | 2.078.006 | 29,906% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Burkina Faso | 5.232.347 | 25,031% | Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing |
| Burundi | 36.321 | 0,305% | Johnson&Johnson, Sinopharm/Beijing |
| Cambodia | 14.693.274 | 87,884% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac |
| Cameroon | 3.197.286 | 12,044% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Canada | 31.758.251 | 84,145% | Johnson&Johnson, Medicago, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Cape Verde | 308.720 | 55,526% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Cayman Islands | 60.696 | 92,355% | Oxford/AstraZeneca, Pfizer/BioNTech |
| Central African Republic | 2.484.985 | 51,451% | Covaxin, Oxford/AstraZeneca |
| Chad | 5.020.360 | 30,564% | Sinopharm/Beijing |
| Chile | 17.700.117 | 92,592% | CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| China | 1.276.760.000 | 88,706% | CanSino, IMBCAMS, KCONVAC, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, ZF2001 |
| Colombia | 37.204.128 | 73,117% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Comoros | 397.080 | 45,663% | Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing |
| Congo | 654.119 | 11,854% | Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V |
| Costa Rica | 4.369.784 | 85,781% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Cote d'Ivoire | 12.164.304 | 46,115% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Croatia | 2.251.809 | 54,852% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Cuba | 10.053.658 | 88,761% | Abdala, Soberana Plus, Soberana02 |
| Curacao | 100.885 | 61,478% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Cyprus | 646.142 | 73,769% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Czechia | 6.895.763 | 64,392% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Democratic Republic of Congo | 14.399.520 | 16,078% | Oxford/AstraZeneca |
| Denmark | 4.712.002 | 81,351% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Djibouti | 401.208 | 40,608% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Dominica | 30.659 | 42,587% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Dominican Republic | 6.130.377 | 56,512% | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac |
| Ecuador | 14.240.587 | 80,715% | CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Egypt | 42.337.175 | 41,371% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| El Salvador | 4.344.286 | 66,977% | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac |
| Equatorial Guinea | 214.032 | 15,255% | Sinopharm/Beijing, Sinovac |
| Estonia | 862.748 | 65,038% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Eswatini | 427.335 | 36,834% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech |
| Ethiopia | 43.653.006 | 37,971% | Covaxin, Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac |
| Falkland Islands | 1.775 | 50,962% | Oxford/AstraZeneca |
| Fiji | 641.194 | 71,526% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Finland | 4.347.113 | 78,458% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| France | 53.192.478 | 81,492% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK |
| French Polynesia | 186.803 | 66,501% | Johnson&Johnson, Pfizer/BioNTech |
| Gabon | 257.471 | 11,568% | Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Gambia | 539.186 | 22,311% | Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing |
| Georgia | 1.276.173 | 31,991% | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac |
| Germany | 63.563.414 | 75,866% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Valneva |
| Ghana | 10.780.003 | 34,693% | Oxford/AstraZeneca, Sputnik V |
| Gibraltar | 41.465 | 123,074% | Oxford/AstraZeneca, Pfizer/BioNTech |
| Greece | 7.647.076 | 73,367% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Greenland | 38.511 | 67,834% | Moderna |
| Grenada | 39.034 | 34,691% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Guatemala | 7.126.305 | 39,777% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V |
| Guernsey | 52.710 | 78,611% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Guinea | 5.853.990 | 44,575% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V |
| Guinea-Bissau | 547.637 | 27,827% | Oxford/AstraZeneca, Sinopharm/Beijing |
| Guyana | 381.984 | 48,564% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Haiti | 366.339 | 3,213% | Johnson&Johnson, Moderna |
| Honduras | 5.853.689 | 59,101% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V |
| Hong Kong | 6.803.327 | 90,703% | Pfizer/BioNTech, Sinovac |
| Hungary | 6.207.249 | 64,255% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Iceland | 290.193 | 85,038% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| India | 951.990.552 | 68,985% | Corbevax, Covaxin, Novavax, Oxford/AstraZeneca, Sputnik V |
| Indonesia | 174.965.137 | 63,967% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac |
| Iran | 58.585.264 | 69,750% | COVIran Barekat, CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Soberana02, Sputnik Light, Sputnik V |
| Iraq | 7.944.775 | 19,752% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Ireland | 4.065.584 | 82,336% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Isle of Man | 67.106 | 78,919% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Israel | 6.159.825 | 71,166% | Moderna, Pfizer/BioNTech |
| Italy | 47.947.097 | 79,301% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK |
| Jamaica | 760.132 | 25,670% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Japan | 103.380.343 | 81,739% | Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Jersey | 81.882 | 81,013% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Jordan | 4.558.313 | 44,676% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Kazakhstan | 10.629.063 | 56,608% | Pfizer/BioNTech, QazVac, Sinopharm/Beijing, Sinovac, Sputnik V |
| Kenya | 11.090.440 | 20,625% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Kosovo | 825.082 | 42,689% | Oxford/AstraZeneca, Pfizer/BioNTech |
| Kuwait | 3.346.176 | 78,354% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Kyrgyzstan | 1.406.016 | 21,551% | Sinopharm/Beijing, Sputnik V |
| Laos | 5.222.417 | 71,780% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Latvia | 1.305.976 | 69,238% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Lebanon | 2.414.223 | 35,371% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Lesotho | 938.088 | 43,790% | Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing |
| Liberia | 3.730.967 | 73,768% | Oxford/AstraZeneca |
| Libya | 1.236.102 | 17,989% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Lithuania | 1.881.106 | 69,100% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Luxembourg | 462.702 | 73,917% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Madagascar | 2.628.849 | 9,494% | Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing |
| Malawi | 4.288.014 | 22,415% | Johnson&Johnson, Oxford/AstraZeneca |
| Malaysia | 27.551.144 | 85,124% | CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac |
| Maldives | 385.167 | 71,256% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V |
| Mali | 3.633.589 | 17,943% | Oxford/AstraZeneca |
| Malta | 471.565 | 106,800% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Mauritania | 1.540.597 | 33,134% | Oxford/AstraZeneca, Sinopharm/Beijing |
| Mauritius | 1.088.142 | 85,561% | Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing |
| Mexico | 81.849.962 | 63,483% | CanSino, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V |
| Moldova | 1.078.961 | 26,747% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V |
| Monaco | 25.667 | 65,404% | Pfizer/BioNTech |
| Mongolia | 2.175.617 | 66,364% | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Montenegro | 284.869 | 45,357% | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Montserrat | 1.952 | 39,048% | Oxford/AstraZeneca |
| Morocco | 23.521.989 | 63,727% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Mozambique | 21.329.745 | 68,243% | Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing |
| Myanmar | 35.937.796 | 66,050% | Oxford/AstraZeneca, Sinopharm/Beijing |
| Namibia | 550.978 | 21,684% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Nepal | 24.471.043 | 83,987% | Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Netherlands | 11.768.644 | 68,682% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| New Caledonia | 184.816 | 64,736% | Pfizer/BioNTech |
| New Zealand | 4.291.717 | 88,999% | Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Nicaragua | 6.126.708 | 92,485% | Abdala, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Soberana02, Sputnik Light, Sputnik V |
| Niger | 5.483.001 | 22,651% | Oxford/AstraZeneca, Sinopharm/Beijing |
| Nigeria | 81.297.808 | 39,438% | Oxford/AstraZeneca |
| North Macedonia | 838.181 | 40,232% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, Sputnik V |
| Norway | 4.054.726 | 74,793% | Moderna, Pfizer/BioNTech |
| Oman | 3.048.826 | 59,703% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Pakistan | 140.475.871 | 63,595% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Palestine | 1.776.973 | 34,833% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Panama | 3.174.155 | 73,565% | Oxford/AstraZeneca, Pfizer/BioNTech |
| Papua New Guinea | 321.192 | 3,590% | Oxford/AstraZeneca |
| Paraguay | 3.546.685 | 49,725% | Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V |
| Peru | 28.709.644 | 87,073% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Philippines | 78.443.972 | 71,585% | Covaxin, Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Poland | 22.649.355 | 59,845% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Portugal | 8.909.769 | 87,379% | Covaxin, Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK, Sinopharm/Beijing, Sinovac |
| Qatar | 2.852.178 | 98,998% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Romania | 8.114.769 | 42,182% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Russia | 79.702.396 | 54,615% | EpiVacCorona, Sputnik V |
| Rwanda | 10.399.665 | 80,293% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V |
| Saint Kitts and Nevis | 27.000 | 50,760% | Oxford/AstraZeneca, Pfizer/BioNTech |
| Saint Lucia | 54.971 | 29,936% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Saint Vincent and the Grenadines | 31.632 | 28,511% | Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik Light, Sputnik V |
| Samoa | 177.954 | 87,879% | Oxford/AstraZeneca |
| San Marino | 23.633 | 69,636% | Pfizer/BioNTech, Sputnik V |
| Sao Tome and Principe | 111.986 | 51,098% | Oxford/AstraZeneca |
| Saudi Arabia | 25.433.941 | 73,057% | Oxford/AstraZeneca, Pfizer/BioNTech |
| Senegal | 1.546.628 | 9,237% | Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing |
| Serbia | 3.278.198 | 48,176% | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Seychelles | 83.565 | 84,976% | Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V |
| Sierra Leone | 4.961.886 | 62,203% | Oxford/AstraZeneca, Sinopharm/Beijing |
| Singapore | 5.120.969 | 87,533% | Moderna, Novavax, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac |
| Sint Maarten (Dutch part) | 26.773 | 62,434% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Slovakia | 2.577.827 | 47,216% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V |
| Slovenia | 1.222.225 | 58,791% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Solomon Islands | 254.352 | 37,030% | Oxford/AstraZeneca |
| Somalia | 7.666.835 | 48,240% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| South Africa | 21.038.797 | 35,473% | Johnson&Johnson, Pfizer/BioNTech |
| South Korea | 44.372.679 | 86,548% | Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| South Sudan | 4.273.253 | 38,175% | Johnson&Johnson, Oxford/AstraZeneca |
| Spain | 40.739.123 | 87,134% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Sri Lanka | 14.752.827 | 68,896% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Sudan | 13.416.394 | 30,597% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Suriname | 237.879 | 40,550% | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Sweden | 7.593.676 | 75,190% | Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Syria | 2.358.365 | 13,476% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Taiwan | 20.793.089 | 87,304% | Medigen, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech |
| Tajikistan | 5.191.919 | 54,436% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V |
| Tanzania | 32.165.791 | 53,848% | Johnson&Johnson, Pfizer/BioNTech, Sinopharm/Beijing |
| Thailand | 53.486.086 | 76,628% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac |
| Togo | 1.554.066 | 18,772% | Oxford/AstraZeneca |
| Trinidad and Tobago | 716.898 | 51,226% | Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Tunisia | 6.401.841 | 54,167% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Turkey | 53.176.961 | 63,051% | Pfizer/BioNTech, Sinovac, Turkovac |
| Turks and Caicos Islands | 30.710 | 79,317% | Pfizer/BioNTech |
| Uganda | 13.061.126 | 28,555% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Ukraine | 15.741.036 | 35,993% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| United Arab Emirates | 9.792.266 | 99,008% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| United Kingdom | 50.762.968 | 74,777% | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| United States | 230.637.348 | 69,678% | Johnson&Johnson, Moderna, Novavax, Pfizer/BioNTech |
| Uruguay | 2.903.089 | 83,573% | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Uzbekistan | 18.451.781 | 55,131% | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik Light, Sputnik V, ZF2001 |
| Vanuatu | 162.250 | 52,713% | Oxford/AstraZeneca |
| Venezuela | 14.966.671 | 52,633% | Abdala, Sinopharm/Beijing, Sinovac, Soberana02, Sputnik Light, Sputnik V |
| Vietnam | 85.961.564 | 88,312% | Abdala, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Wallis and Futuna | 6.803 | 60,493% | Moderna |
| World | 5.177.942.957 | 67,129% | - |
| Yemen | 807.057 | 2,706% | CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V |
| Zambia | 9.213.802 | 50,119% | Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing |
| Zimbabwe | 4.751.270 | 31,967% | Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V |